ciclopirox has been researched along with Invasiveness, Neoplasm in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciclopirox (CPX) is an antifungal drug that has recently been reported to act as a potential anticancer drug." | 5.62 | Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling. ( Cai, L; Chen, L; Han, S; Jin, Q; Li, Q; Liu, Y; Lu, B; Lu, J; Shangguan, F; Su, Z; Tian, X; Wang, C; Wang, L; Yu, S; Zheng, W; Zhou, N, 2021) |
| "However, the effects of CPX on colorectal cancer (CRC) and the underlying mechanisms for its antitumor activity remain unclear." | 5.56 | Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer. ( Chen, Q; Chen, T; Deng, Y; Li, L; Lu, B; Mo, S; Qi, J; Shan, C; Zhou, N; Zhou, Y, 2020) |
| "Ciclopirox (CPX) is an antifungal drug that has recently been reported to act as a potential anticancer drug." | 1.62 | Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling. ( Cai, L; Chen, L; Han, S; Jin, Q; Li, Q; Liu, Y; Lu, B; Lu, J; Shangguan, F; Su, Z; Tian, X; Wang, C; Wang, L; Yu, S; Zheng, W; Zhou, N, 2021) |
| "However, the effects of CPX on colorectal cancer (CRC) and the underlying mechanisms for its antitumor activity remain unclear." | 1.56 | Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer. ( Chen, Q; Chen, T; Deng, Y; Li, L; Lu, B; Mo, S; Qi, J; Shan, C; Zhou, N; Zhou, Y, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qi, J | 1 |
| Zhou, N | 2 |
| Li, L | 1 |
| Mo, S | 1 |
| Zhou, Y | 1 |
| Deng, Y | 1 |
| Chen, T | 1 |
| Shan, C | 1 |
| Chen, Q | 1 |
| Lu, B | 2 |
| Su, Z | 1 |
| Han, S | 1 |
| Jin, Q | 1 |
| Lu, J | 2 |
| Shangguan, F | 1 |
| Yu, S | 1 |
| Liu, Y | 1 |
| Wang, L | 1 |
| Li, Q | 1 |
| Cai, L | 1 |
| Wang, C | 1 |
| Tian, X | 1 |
| Chen, L | 1 |
| Zheng, W | 1 |
2 other studies available for ciclopirox and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer.
Topics: Aerobiosis; Animals; Apoptosis; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cel | 2020 |
Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bortezomib; Brain Neoplasms; Cel | 2021 |